Archive: 07/11/2017

Steroid-releasing sinus implant deemed effective, safe

(HealthDay)—For patients with chronic rhinosinusitis (CRS), placement of an hourglass-shaped bioabsorbable, steroid-releasing sinus implant improves postoperative outcomes when placed in the frontal sinus ostia (FSO) after ...

Nov 7, 2017

0

0

Tezacaftor-ivacaftor, ivacaftor alone effective in CF

(HealthDay)—Tezacaftor-ivacaftor or ivacaftor alone is effective for patients with cystic fibrosis who are heterozygous for the Phe508del deletion, and tezacaftor-ivacaftor is effective for patients who are homozygous for ...

Nov 7, 2017

0

0

Cancer research – how a traffic jam causes tumor growth

For tissues to cooperate and perform normal functions, cells need to know which way is up. When cells lose track of their orientation, they can start to grow out of control, and develop into cancer. Now, a team of researchers ...

Nov 7, 2017

0

5

Stress, fear of pain may be cause of painful sickle cell episodes

Mental stress and the anticipation of pain may cause blood vessels to narrow and trigger episodes of severe pain (vaso-occlusive crisis, or VOC) in sickle cell disease (SCD). A team of researchers from California will present ...

Nov 7, 2017

Imaging may provide a new tool to track progression of calcific aortic-valve disease

Almost a half million Americans aged 65 to 74 suffer from a degenerative cardiovascular disease caused by calcium being deposited in heart tissue, and many will need valve replacement surgery to prevent heart failure. Currently ...

Nov 7, 2017

0

93

Big data analysis predicts risk of radiotherapy side effects

Analysing big data to predict men's risk of side effects could help personalise radiotherapy treatment for prostate cancer, according to new research presented at the National Cancer Research Institute's (NCRI) Cancer Conference ...

Nov 7, 2017

0

3

Global nutrition crisis threatens human development, major new report finds

Almost every country in the world now faces a serious nutrition-related challenge, according to a new report co-authored by a City expert.

Nov 7, 2017

0

2

Selective PDE4D inhibitor shows potential to treat Fragile X autism spectrum disorder

New preclinical research suggests the potential utility of BPN14770, a selective PDE4D inhibitor currently under development by Tetra Discovery Partners as a prospective treatment for memory and cognitive problems associated ...

Nov 7, 2017